Thromb Haemost 2012; 107(06): 1189-1191
DOI: 10.1160/TH11-11-0788
Letters to the Editor
Schattauer GmbH

Dabigatran etexilate (Pradaxa®) for preventing warfarin-induced skin necrosis in a patient with severe protein C deficiency

Authors

  • Cedric Hermans

    1   Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
  • Stéphane Eeckhoudt

    2   Hemostasis and Thrombosis Laboratory, Division of Biological Chemistry, Cliniques Universitaires Saint-Luc, Brussels, Belgium
  • Catherine Lambert

    1   Hemostasis and Thrombosis Unit, Division of Adult Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium
Weitere Informationen

Publikationsverlauf

Received: 14. November 2011

Accepted after major revision: 21. Februar 2012

Publikationsdatum:
29. November 2017 (online)

Preview